September 2016
Volume 57, Issue 12
Open Access
ARVO Annual Meeting Abstract  |   September 2016
Evaluation of contrast sensitivity function in individuals with Fabry disease
Author Affiliations & Notes
  • Pinakin Gunvant Davey
    College of Optometry, Western University of Health Sciences, Pomona, California, United States
  • Kaydee McCray
    College of Optometry, Western University of Health Sciences, Pomona, California, United States
  • Footnotes
    Commercial Relationships   Pinakin Davey, None; Kaydee McCray, None
  • Footnotes
    Support  National Fabry Disease Foundation
Investigative Ophthalmology & Visual Science September 2016, Vol.57, 618. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Pinakin Gunvant Davey, Kaydee McCray; Evaluation of contrast sensitivity function in individuals with Fabry disease. Invest. Ophthalmol. Vis. Sci. 2016;57(12):618.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Fabry disease is a rare genetic lysosomal storage disorder (1 in 117,000 people) that leads to progressive accumulation of globotriaosylceramide deposits in a variety of cells including cornea which leads to development of cornea verticillata. Not all individuals show a visible deposit and cornea verticillata but have intracellular deposits when examined under a corneal confocal microscope. We sought to investigate if individuals with Fabry disease have decreased contrast sensitivity function when compared to ocular healthy adults.

Methods : A total of sixty seven individuals were included in the study (32 Fabry and 35 healthy controls). The measurements of distance and near visual acuity, slit lamp examination, anterior and posterior segment photography and optical coherence tomography measurements (both macula and optic nerve) were obtained. Individuals also underwent binocular contrast sensitivity function (CSF) measurement with a portable near Quick CSF (Adaptive Sensory Technology, Boston MA) which uses Bayesian inference and a trial-to-trial information gain strategy to obtain rapid measurements of contrast sensitivity. The CSF was measured with 50 trials and estimates of area under the log CSF (AULCSF), high spatial frequency cutoff (CSF acuity), and contrast sensitivity at 1, 1.5, 3, 6, 12 and 18 cycles per degree (cpd) were obtained.

Results : The mean age and standard deviation of ocular healthy group and Fabry group was 36.22 SD 6.4 and 37.83 SD 10.6. The mean age and logmar visual acuity distance and near were not significantly different between the groups (Independent samples t-test p=0.54 , 0.07 and 0.08 respectively). The CSF values did not follow a normal distribution (Kolmogorov-Smirnov test p< 0.05). The CSF function at all spatial frequencies were lower in Fabry group compared to the ocular healthy group. The AULCSF and CS at 1, 1.5, 3 and 6 CPD were significantly lower in the Fabry group compared to the ocular healthy group (Mann-Whitney p<0.05). The CSF acuity and CS at 12 and 18 CPD were not significantly different between the groups (Mann-Whitney p>0.05) (see Figure 1)

Conclusions : The mean CSF at the low and the mid spatial frequencies region is lower in Fabry group compared to the healthy group whereas CSF in high spatial frequencies region and visual acuity are not significantly different. This may in part be responsible for the vision related issues reported by patients with Fabry disease.

This is an abstract that was submitted for the 2016 ARVO Annual Meeting, held in Seattle, Wash., May 1-5, 2016.

 

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×